HLB Life Science announced on the 17th that a stock pledge agreement involving a change in the largest shareholder has been signed.



The pledge provider is HLB, owning 20,695,725 shares, accounting for 17.44% of the stake. The creditor, Mirae Asset Securities, has set a total collateral amount of 150 billion KRW, with 20,695,725 shares pledged as collateral. The collateral period is from the 21st of this month to November 21st.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing